Cookie Policy

Mereo BioPharma Group plc's website uses cookies. By continuing to browse you are agreeing to our use of cookies. Find out more about our Cookie Policy.

MREO: US$2.69
Mereo-Banner-Image.jpg

Working together to inspire, innovate and improve lives

See our latest news

News

14 Jan 2021 Notice of General Meeting
17 Dec 2020 Mereo BioPharma and Ultragenyx Announce Collaboration and License Agreement for Setrusumab in Osteogenesis Imperfecta
15 Dec 2020 Update on AIM Delisting and agreements with SVB & Kreos Capital
Press Releases

View our latest Corporate Presentation

section-img.jpg
20 JAN 2021 CORPORATE PRESENTATION
24 NOV 2020 Virtual R&D Day, Tuesday, November 24, 2020 - 12:00 p.m. EST / 5:00 p.m. GMT Replay webcast
profile-img.jpg
quote.svg

We continue to make strong progress in development of our product portfolio, in the hope of providing better treatment options for patients with life limiting oncology and rare diseases

Denise Scots-Knight, CEO Our Mission